Cheryl R. Blanchard
2021 - Anika Therapeutics
In 2021, Cheryl R. Blanchard earned a total compensation of $4.2M as President and Chief Executive Officer at Anika Therapeutics, a 58% decrease compared to previous year.
Compensation breakdown
| Bonus | $568,140 |
|---|---|
| Option Awards | $1,471,831 |
| Salary | $668,400 |
| Stock Awards | $1,470,806 |
| Other | $23,431 |
| Total | $4,202,608 |
Blanchard received $1.5M in option awards, accounting for 35% of the total pay in 2021.
Blanchard also received $568.1K in bonus, $668.4K in salary, $1.5M in stock awards and $23.4K in other compensation.
Rankings
In 2021, Cheryl R. Blanchard's compensation ranked 3,179th out of 12,404 executives tracked by ExecPay. In other words, Blanchard earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,179 out of 12,404 | 74th |
Division Manufacturing | 1,285 out of 5,494 | 77th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 153 out of 798 | 81st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 99 out of 519 | 81st |
Industry Surgical and Medical Instruments and Apparatus | 67 out of 324 | 79th |
Source: SEC filing on April 27, 2022.
Blanchard's colleagues
We found four more compensation records of executives who worked with Cheryl R. Blanchard at Anika Therapeutics in 2021.